Boxer Capital LLC 13D and 13G filings for Fate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 6:06 pm Purchase |
2024-01-31 | 13G | Fate Therapeutics, Inc. FATE |
Boxer Capital LLC | 6,171,000 6.300% |
6,171,000 (New Position) |
Filing |